THYROID GLAND MEDULLARY CARCINOMA
Clinical trials for THYROID GLAND MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shrinks thyroid tumors before surgery in early trial
Disease control OngoingThis phase 2 trial tests the drug selpercatinib given before surgery in 30 people with thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if the drug can shrink tumors and make surgery more successful. Participants take selpercatinib for a shor…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a drug called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to standard therapy. The drug works by blocking enzymes that help tumors grow and form blood vesse…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New imaging agent could spot hidden cancers
Diagnosis OngoingThis study tests a special PET scan that uses a radioactive antibody (64Cu-M5A) to find cancers that produce a protein called CEA. About 20 adults with various CEA-positive cancers will receive the injection and have scans over two days. The goal is to see if this method can dete…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC